Quick Answer
CYTOKINETICS INC reported Research And Development Expense of $416.03 million for the year ending 2025.
- CYTOKINETICS INC showed an increase of +22.6% in Research And Development Expense from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $9.18 million | Q2 2011: $10.51 million | Q3 2011: $8.89 million | Q1 2012: $8.75 million | Q2 2012: $8.24 million | Q3 2012: $8.80 million | Q1 2013: $9.83 million | Q2 2013: $12.35 million | Q3 2013: $13.45 million | Q1 2014: $12.49 million | Q2 2014: $11.74 million | Q3 2014: $11.42 million | Q1 2015: $8.96 million | Q2 2015: $12.64 million | Q3 2015: $11.56 million | Q1 2016: $13.53 million | Q2 2016: $9.72 million | Q3 2016: $17.87 million | Q1 2017: $19.29 million | Q2 2017: $19.81 million | Q3 2017: $24.95 million | Q1 2018: $22.14 million | Q2 2018: $21.58 million | Q3 2018: $21.39 million | Q1 2019: $23.55 million | Q2 2019: $24.02 million | Q3 2019: $20.23 million | Q1 2020: $21.74 million | Q2 2020: $21.79 million | Q3 2020: $24.20 million | Q1 2021: $31.56 million | Q2 2021: $36.44 million | Q3 2021: $48.44 million | Q1 2022: $45.94 million | Q2 2022: $57.13 million | Q3 2022: $62.73 million | Q1 2023: $79.42 million | Q2 2023: $83.19 million | Q3 2023: $82.53 million | Q1 2024: $81.57 million | Q2 2024: $79.60 million | Q3 2024: $84.61 million | Q1 2025: $99.84 million | Q2 2025: $112.55 million | Q3 2025: $99.23 million.
- Over the full 17 years of available data (2009 to 2025), CYTOKINETICS INC's Research And Development Expense has grown by 944.2%.
- Historical annual values: Fiscal year 2025: $416.03 million | Fiscal year 2024: $339.41 million | Fiscal year 2023: $330.12 million | Fiscal year 2022: $240.81 million | Fiscal year 2021: $159.94 million | Fiscal year 2020: $96.95 million | Fiscal year 2019: $86.13 million | Fiscal year 2018: $89.14 million | Fiscal year 2017: $90.30 million | Fiscal year 2016: $59.90 million | Fiscal year 2015: $46.40 million | Fiscal year 2014: $44.43 million | Fiscal year 2013: $49.45 million | Fiscal year 2012: $35.64 million | Fiscal year 2011: $37.18 million | Fiscal year 2010: $38.01 million | Fiscal year 2009: $39.84 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: